News Releases

The University of Pennsylvania Health System has formed a joint venture with Nashville-based Evergreen Nephrology to improve care for patients with chronic and end-stage kidney disease while containing costs through innovative approaches to provide more care, including dialysis, at home, reduce the need for emergency department visits and hospitalizations, and get kidney transplants sooner.

By uncovering the subtle difference between two varieties of a protein, researchers from the Perelman School of Medicine at the University of Pennsylvania may have discovered how to eliminate the risk of weight gain from a certain type of diabetes medications.

While gene mutations can lead to drug resistance, researchers in the Perelman School of Medicine at the University of Pennsylvania have identified an important, non-genetic adaptation that could also drive resistance to targeted therapy in T cell leukemia, a type of blood cell cancer. Their findings were published this month in Molecular Cell.

The Department of Radiation Oncology will use the $12.3 million, five-year NIH grant to compare the ability of proton, carbon and electron radiotherapy to protect normal tissues from harmful effects while controlling or eradicating solid tumors of the gastrointestinal tract, lungs, soft tissues throughout the body, and bones.

For the first time, researchers have revealed that during the development of Type 1 Diabetes (T1D), when insulin-producing cells in the pancreas are under attack from T lymphocytes, the cells lining the pancreatic duct reprogram themselves in an attempt to suppress autoimmune T cell responses.

The Perelman School of Medicine at the University of Pennsylvania came in at number one for the most funds awarded to a United States orthopaedic surgery department by the National Institutes of Health (NIH) in 2021.